ScholarIQanswers from OpenAlex
Journal of Dermatological Treatment
JournalCitation impact & published research
Journal of Dermatological Treatment is a journal indexed in ScholarIQ from OpenAlex.
What is the OpenAlex record for Journal of Dermatological Treatment?
ScholarIQopenalex
The OpenAlex for Journal of Dermatological Treatment is on the source record.
What are the most-cited papers on Journal of Dermatological Treatment?
ScholarIQmost cited works
A systematic review and meta-analysis of the efficacy and safety of the interleukin (IL)-12/23 and IL-17 inhibitors ustekinumab, secukinumab, ixekizumab, brodalumab, guselkumab and tildrakizumab for the treatment of moderate to severe plaque psoriasis
Jawad Bilal, Adam Berlinberg, Sandipan Bhattacharjee, Jaren R. Trost, Irbaz Bin Riaz, Drew J.B. Kurtzman
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis
Maria Concetta Fargnoli, Maria Esposito, Silvia Mariel Ferrucci, Giampiero Girolomoni, Annamaria Offidani, Annalisa Patrizi, Ketty Peris, Antonio Costanzo, Giovanna Malara, Giovanni Pellacani, Marco Romanelli, Paolo Amerio, Antonio Cristaudo, Maria Laura Flori, Alberico Motolese, P. Betto, Cataldo Patruno, Paolo D. Pigatto, Riccardo Sirna, Giuseppe Stinco, Iris Zalaudek, Luca Bianchi, Valeria Boccaletti, S.P. Cannavò, Francesco Cusano, Serena Lembo, R. Mozzillo, Rosella Gallo, Concetta Potenza, Franco Rongioletti, R. Tiberio, Teresa Grieco, Giuseppe Micali, Severino Persechino, M. Pettinato, Sabina Pucci, Eleonora Savi, Luca Stingeni, Alberto Romano, Giuseppe Argenziano, On behalf of the Dupilumab Italian National Access Program (Dup-INAP group)
Redefining the therapeutic objective in psoriatic patients candidates for biological therapy
G. Carretero, L. Puig, J.M. Carrascosa, Lara Ferrándiz, Ricardo Ruíz‐Villaverde, P. de la Cueva, I. Belinchón, Eva Vilarrasa, Ruth del Río, J.L. Sánchez‐Carazo, Anna López‐Ferrer, Fernando Zamanillo Peral, Susana Armesto, Noemí Eirís, J. Mitxelena, J. Vilar-Alejo, Mariano Ara Martín, C. Soria, from the Spanish Group of Psoriasis
Sustained response with ixekizumab treatment of moderate-to-severe psoriasis with scalp involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2, UNCOVER-3)
Kristian Reich, Craig L. Leonardi, Mark Lebwohl, Francisco A. Kerdel, Yukari Okubo, Ricardo Romiti, Orin M. Goldblum, Ellen B. Dennehy, Lisa Kerr, Howard Sofen
Vehicles for atopic dermatitis therapies: more than just a placebo
Simon G. Danby, Zoe Diana Draelos, Linda Stein Gold, Amy Cha, Bonnie Vlahos, Laraine Aikman, Paul W. Sanders, Dan Wu‐Linhares, Michael J. Cork